감기 및 독감 보충제 시장 : 유형, 형태, 유통 채널별 - 세계 예측(2025-2030년)

The Cold & Flu Supplements Market was valued at USD 16.78 billion in 2023, expected to reach USD 18.57 billion in 2024, and is projected to grow at a CAGR of 10.90%, to USD 34.65 billion by 2030.

The cold and flu supplements market encompasses nutritional products designed to bolster immune function and alleviate symptoms associated with common colds and flu. These supplements often include vitamins, minerals, herbs, and amino acids, often formulated to support overall immune health and mitigate symptom severity. They are considered critical for preventing viral infections and recovering more swiftly, especially during peak seasons like fall and winter. The application of these supplements extends across different consumer demographics, including children, adults, and the elderly, with end-users ranging from health-conscious individuals to those seeking alternative solutions alongside conventional medicine.

The market thrives due to increased health awareness, especially after recent global health crises emphasizing immune resilience. The trend towards preventive healthcare and natural supplements has driven significant growth, alongside online sales channels expanding market reach. Innovations in formulation and the growing trend for personalized nutrition are opening new avenues for product development, catering to a more individualized consumer experience. Despite these growth factors, the market faces significant challenges, including regulatory hurdles, the need for clinical validation of product efficacy, and competition from pharmaceuticals. Consumer skepticism regarding the effectiveness of some supplements further complicates market dynamics.

Potential opportunities lie in research and innovation, particularly in the development of scientifically backed supplements with proven health benefits. Companies can leverage digital platforms for innovative marketing strategies and consumer education initiatives that enhance product credibility. Additionally, expanding into emerging markets can provide access to a broader consumer base willing to invest in preventative healthcare solutions. However, companies need to maintain transparency in labeling and gather substantive scientific evidence to mitigate regulatory challenges and overcome consumer skepticism. This market demands continuous innovation, consumer engagement, and a focus on robust clinical research to sustain growth and establish trust among consumers seeking effective health interventions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cold & Flu Supplements Market

The Cold & Flu Supplements Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Seasonal disease outbreaks and concerns about immune health of aging population
  • Rising consumer awareness through government health programs and initiatives
  • Emerging preferences for natural and herbal supplements
• Market Restraints
  • Wider availability of pharmaceutical alternatives
• Market Opportunities
  • Ongoing introduction of newly developed immunity booster supplements
  • Growing expansion of supermarkets and online distribution channels
• Market Challenges
  • Challenges associated with maintaining product quality and adhering to regulatory requirements

Porter's Five Forces: A Strategic Tool for Navigating the Cold & Flu Supplements Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cold & Flu Supplements Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cold & Flu Supplements Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cold & Flu Supplements Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cold & Flu Supplements Market

A detailed market share analysis in the Cold & Flu Supplements Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cold & Flu Supplements Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cold & Flu Supplements Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cold & Flu Supplements Market

A strategic analysis of the Cold & Flu Supplements Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cold & Flu Supplements Market, highlighting leading vendors and their innovative profiles. These include Amway International Inc., Bayer AG, Church & Dwight Co., Inc., GlaxoSmithKline PLC, Haleon PLC, Himalaya Global Holdings Ltd., Johnson & Johnson Services Inc., Medique Products, Mondelez Global LLC, Nature's Sunshine Products, Inc., Nature's Way, Inc., Neurobiologix, Inc., Nutraceutical Corporation, Perrigo Company PLC, Reckitt Benckiser Group PLC, Sambucol by PharmaCare Laboratories Pty Ltd., Sun Pharmaceutical Industries Ltd., The Menarini Group, The Procter & Gamble Company, Thornton and Ross Limited by STADA Group, and Wakunaga Pharmaceutical Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Cold & Flu Supplements Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Herbal Extracts, Homeopathic, Natural Molecules, and Vitamins & Minerals.
• Based on Form, market is studied across Pills & Capsules, Powders, and Syrups.
• Based on Distribution Channel, market is studied across Online & E-commerce Platforms and Pharmacies & Drug Stores.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Seasonal disease outbreaks and concerns about immune health of aging population
    • 5.1.1.2. Rising consumer awareness through government health programs and initiatives
    • 5.1.1.3. Emerging preferences for natural and herbal supplements
  • 5.1.2. Restraints
    • 5.1.2.1. Wider availability of pharmaceutical alternatives
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing introduction of newly developed immunity booster supplements
    • 5.1.3.2. Growing expansion of supermarkets and online distribution channels
  • 5.1.4. Challenges
    • 5.1.4.1. Challenges associated with maintaining product quality and adhering to regulatory requirements
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cold & Flu Supplements Market, by Type

• 6.1. Introduction
• 6.2. Herbal Extracts
• 6.3. Homeopathic
• 6.4. Natural Molecules
• 6.5. Vitamins & Minerals

7. Cold & Flu Supplements Market, by Form

• 7.1. Introduction
• 7.2. Pills & Capsules
• 7.3. Powders
• 7.4. Syrups

8. Cold & Flu Supplements Market, by Distribution Channel

• 8.1. Introduction
• 8.2. Online & E-commerce Platforms
• 8.3. Pharmacies & Drug Stores

9. Americas Cold & Flu Supplements Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Cold & Flu Supplements Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Cold & Flu Supplements Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Amway International Inc.
• 2. Bayer AG
• 3. Church & Dwight Co., Inc.
• 4. GlaxoSmithKline PLC
• 5. Haleon PLC
• 6. Himalaya Global Holdings Ltd.
• 7. Johnson & Johnson Services Inc.
• 8. Medique Products
• 9. Mondelez Global LLC
• 10. Nature's Sunshine Products, Inc.
• 11. Nature's Way, Inc.
• 12. Neurobiologix, Inc.
• 13. Nutraceutical Corporation
• 14. Perrigo Company PLC
• 15. Reckitt Benckiser Group PLC
• 16. Sambucol by PharmaCare Laboratories Pty Ltd.
• 17. Sun Pharmaceutical Industries Ltd.
• 18. The Menarini Group
• 19. The Procter & Gamble Company
• 20. Thornton and Ross Limited by STADA Group
• 21. Wakunaga Pharmaceutical Co., Ltd.